- Home
- SWTX vs DLO Comparison
SWTX vs DLO Comparison
Compare SWTX & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- DLO
- Stock Information
- Founded
- SWTX 2017
- DLO 2013
- Country
- SWTX United States
- DLO Uruguay
- Employees
- SWTX N/A
- DLO N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- DLO Business Services
- Sector
- SWTX Health Care
- DLO Consumer Discretionary
- Exchange
- SWTX Nasdaq
- DLO Nasdaq
- Market Cap
- SWTX 3.0B
- DLO 2.5B
- IPO Year
- SWTX 2019
- DLO 2021
- Fundamental
- Price
- SWTX $37.92
- DLO $8.70
- Analyst Decision
- SWTX Strong Buy
- DLO Hold
- Analyst Count
- SWTX 5
- DLO 9
- Target Price
- SWTX $72.40
- DLO $11.94
- AVG Volume (30 Days)
- SWTX 2.2M
- DLO 690.8K
- Earning Date
- SWTX 05-01-2025
- DLO 05-14-2025
- Dividend Yield
- SWTX N/A
- DLO N/A
- EPS Growth
- SWTX N/A
- DLO N/A
- EPS
- SWTX N/A
- DLO 0.39
- Revenue
- SWTX $191,589,000.00
- DLO $745,974,000.00
- Revenue This Year
- SWTX $85.98
- DLO $30.04
- Revenue Next Year
- SWTX $69.16
- DLO $26.70
- P/E Ratio
- SWTX N/A
- DLO $22.31
- Revenue Growth
- SWTX 3417.33
- DLO 14.70
- 52 Week Low
- SWTX $28.21
- DLO $6.58
- 52 Week High
- SWTX $62.00
- DLO $15.75
- Technical
- Relative Strength Index (RSI)
- SWTX 39.33
- DLO 45.49
- Support Level
- SWTX $36.08
- DLO $7.61
- Resistance Level
- SWTX $38.77
- DLO $8.88
- Average True Range (ATR)
- SWTX 3.21
- DLO 0.49
- MACD
- SWTX -0.17
- DLO 0.13
- Stochastic Oscillator
- SWTX 36.05
- DLO 69.47
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About DLO DLocal Limited
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables global enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.